While inflammation is clearly the primary activator of NF-κB in cancer cells, our work demonstrates that mechanical cues, such as those coming from the loss of cell–cell adhesions, or increases in cell autonomous contractility, can also up-regulate NF-κB activity via changes in cell shape (Sero et al. 2015). Here, NFKB1 is linked to cancer.